ABO and Alzheimer disease: They have shown that this peptide targets AβO aggregates when microinjected into the hippocampi of living double-transgenic AD mice harboring PSEN1dE9 and APPSWE transgenes [73] and also ex vivo in brain sections of both transgenic mice and postmortem human AD patients.